Harvard Bioscience Inc (HBIO) stock news · rev $86.5M
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
This HBIO news page leads with what Harvard Bioscience Inc filed — not a scraped headline mill.
No cached 8-K sentence for HBIO yet. We will not pad this page with generic market recap.
Latest reported HBIO revenue for 2025-12-31 was $86.5M. Net income was -$56.7M. Revenue was down 8.1% from 2024-12-31 to 2025-12-31. HBIO currently screens at market cap $20.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the HBIO stock page; for the tape open the quote page.
HBIO stock news FAQ
What are HBIO's latest revenue and net income?
Latest cached Harvard Bioscience Inc (HBIO) revenue for Dec 31, 2025 was $86.5M. Net income was -$56.7M. Statements: https://lician.com/financials/hbio
How did HBIO revenue change from the prior cached period?
Cached Harvard Bioscience Inc (HBIO) revenue was down 8.1% from $94.1M (Dec 31, 2024) to $86.5M (Dec 31, 2025). Statements: https://lician.com/financials/hbio
What is HBIO's market cap?
Harvard Bioscience Inc (HBIO) market cap is $20.3M on the latest cached fundamentals snapshot.
What kind of company is HBIO?
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Where is HBIO stock news listed?
Cached stock news for Harvard Bioscience Inc (HBIO) is listed at https://lician.com/news/hbio. Filings: https://lician.com/sec/hbio
Not investment advice.